Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

29

Revenue 2017

Soliris

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Soliris was produced by Alexion.

Alexion adds to pipeline rebuild with $855m Wilson buy

Alexion adds to pipeline rebuild with $855m Wilson buy has a long way to go before it bears comparison with Soliris’ $3.1bn turnover. ... Since then it has added to its patents for Soliris and is claiming protection from generic competition out to 2027, although that could of course be challenged in the

Alexion's Soliris gets US approval for myasthenia gravis

Alexion's Soliris gets US approval for myasthenia gravis New neurology indication could contribute $1.2bn to sales, says analysts. Alexion has finally claimed FDA approval for its complement inhibitor Soliris in myasthenia gravis (MG), potentially adding another $1bn-plus ... The US regulator has approved

Germany will be first EU launch market for new Soliris indication

Germany will be first EU launch market for new Soliris indication Soliris available that has demonstrated in clinical studies that it improves patients’ symptoms and their ability to undertake daily activities.”. ... However, Soliris does come with a boxed warning of ‘life-threatening’ and ‘fatal’

NICE broadens access to Alexion's rare disease drug Strensiq

NICE broadens access to Alexion's rare disease drug Strensiq s reliance on its primary product Soliris (eculizumab), its $2.8bn treatment for atypical haemolytic uraemic syndrome (aHUS).

A new decade of disruption: meeting the biosimilar challgenge

A new decade of disruption: meeting the biosimilar challgenge In some cases, more: topping $400, 000 per year, Soliris (eculizumab) is one of the costliest drugs available globally.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...
Spotlight interview: 15 minutes on Independent Medical Education
Celeste Kolanko, Managing Director of Liberum, OPEN Health takes 15 minutes to answer some key questions on independent medical education....

Infographics